Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MRNAthis companyModerna, Inc.	$276.54	-4.06×	1.33×	5.9×	-4.23×	-100.7%	55.3%	-158.1%	-145.2%	-32.6%	-29.7%	-18.0%	0.22×	0.27×	-307.4×	3.29×	0.0%	2	12.95	1	C-
ARCTArcturus Therapeutics Holdings Inc.	$10.42	-2.55×	0.78×	2.5×	0.61×	-144.1%	95.5%	-111.5%	-97.9%	-30.7%	-31.4%	-44.2%	0.12×	3.28×	0×	6.64×	0.0%	1	-0.72	2	C
INOInovio Pharmaceuticals, Inc.	$1.51	-0.96×	3.39×	1,248.52×	-0.57×	-63.4%	100.0%	-132871.3%	-130000.0%	-352.5%	-259.4%	-109.0%	0.39×	0.43×	0×	1.4×	0.0%	0	-54.95	1	C-
NVAXNovavax, Inc.	$10.91	2.47×	-8.52×	0.97×	2.23×	-870.5%	93.7%	50.1%	39.2%	-344.7%	78.0%	-23.0%	-1.95×	0.02×	24.98×	2.13×	0.0%	1	-5.75	2	B-
OGENOragenics, Inc.	$0.35	-0.17×	0.2×	0×	-0×	319.2%	0.0%	0.0%	0.0%	-118.9%	-108.5%	-547310.7%	0.03×	-0.01×	-11.91×	5.64×	0.0%	1	-63.79	2	C+
PCVXVaxcyte, Inc.	$65.33	-8.2×	2.34×	0×	-8.54×	-100.9%	0.0%	0.0%	0.0%	-28.5%	-32.5%	-10.7%	0.09×	-0.07×	0×	7.91×	0.0%	0	13.18	2	C
Peer median	—	-0.96×	0.78×	0.97×	-0×	-100.9%	93.7%	0.0%	0.0%	-118.9%	-32.5%	-44.2%	0.09×	0.02×	0×	5.64×	0.0%	1	-5.75	2	—